Close

Polyamine depletion inhibits norovirus infection by blocking virus-induced apoptosis

Maryna Chaika, Heike Laschin, Marina Pekelis, Carmen Mirabelli, Sandra Niendorf, Christiane E. Wobus, Stefan Taube

Posted on: 2 October 2025 , updated on: 6 October 2025

Preprint posted on 14 September 2025

Stopping norovirus at the gate: Polyamines as a possible new lead for therapeutics against norovirus

Selected by Leonie Brüne

Background

Acute Gastroenteritis (AGE) is a disease caused primarily by Human norovirus (HNoV), an icosahedral positive sense-single-stranded RNA virus [1]. Virus infection affects approximately 685 million people worldwide annually, particularly severe in elderly people, children, and immunocompromised individuals [2]. The virus is transmitted from person to person, whereby healthcare facilities, schools, as well as cruise ships demonstrate common hotspots for outbreaks [3]. Despite considerable scientific interest in a vaccine or pre- and post-infection treatment, the development of suitable drugs remains unsuccessful due to the wide genetic range of the virus [4].

Due to poor system models, therapeutic strategies for norovirus infections remain limited. One of the most promising models for studying the virus is the murine norovirus (MNV), which is the only norovirus species that can be cultivated. During early infection by MNV, the intrinsic apoptosis pathway of host cells is modulated by activation of the Pi3K/Akt signalling pathway, resulting in prolonged cell survival and therefore enhanced virus replication [5].

To ensure a rapid infection cycle in the host cell, viruses rely on cofactors, including polyamines (PAs). Representatives of PAs include putrescine, spermidine, or spermine, which are small, polycationic metabolites derived from amino acid metabolism. Reduction of intracellular PA levels decreases the activation of the apoptotic machinery, as shown by reduced expression of caspase and proapoptotic regulators Bax/Bad, thereby promoting resistance against intrinsic apoptotic stimuli. Since studies performed on other viruses have already demonstrated that the availability of PAs has a demonstrable influence on the replication cycle of the virus, the question remains whether norovirus also falls into this category, potentially uncovering a new target for therapeutic agents.

The paper highlighted here shows that norovirus is also one of the viruses that are PA-dependent, demonstrating that depletion of PAs prevents virus induced cell apoptosis.

Key Findings

Experiments were conducted in immune and epithelial cell types.

PA depletion facilitates reduced infection rate with MNV-1 in various cell lines reversibly: The infection potential of MNV-1 was reduced by increased degradation of PAs spermidine and spermine, triggered by the addition of N¹,N¹¹-diethylnorspermine, an activator of spermine/spermidine N¹-acetyltransferase 1 (SAT1). By adding the inhibitor difluoromethylornithine (DFMO), the synthesis of PAs is slowed down, resulting in reduced levels. This demonstrated a significant inhibition of MNV infection. Addition of spermine or spermidine could restore the infection potential.

Reduced PA levels decrease MNV-1 virion release: Cells were treated with DFMO four days prior to the actual infection in order to draw conclusions about a possible release phenotype. It was shown that PAs are relevant in the early stages of infection and that depletion of PAs results in reduced virion release.

PA depletion demonstrates positive effect on cell apoptosis of infected cell lines: MNV-1 infection led to a loss of uncleaved PARP, a marker for cell apoptosis. In PA depleted cell lines, no virus-induced loss of PARP occurred 24 hpi, suggesting apoptosis inhibition. Thereby, induced cell death is mediated via the PI3K/Akt signalling pathway, as LY294002, an inhibitor of PI3K, restores apoptosis in PA-depleted cells.

Why I highlight this work

Noroviruses are not among the viruses commonly discussed in the media because they have to compete with epidemiologically much stronger pathogens such as SARS-Cov2, Ebola, and measles, especially in America, which does not detract them from their clinical relevance.

Nevertheless, research into noroviruses is important, as shown by the increasing incidence of cases in the US [6], in order to generate reliable active substances for both treatment and prevention of infection. The paper highlighted in this post paves the way for possible therapeutic approaches by analysing the role of PAs in the context of a norovirus infection. I find the use of the inhibitor DFMO particularly promising, which is currently already in clinical trials for the treatment of trypanosomosis, so why not also for norovirus? As the paper has shown, the use of the inhibitor and the associated depletion of PAs leads to reduced virion release and reduced cell apoptosis, interesting and promising especially for patients with chronic norovirus infection or for prevention in hotspot regions. It will be interesting to see whether PAs can play a key role in the discovery of new drugs for the treatment of noroviruses.

I am certainly no expert in the field of virology, but I would also recommend this article to people who have found their profession in other areas. Thanks to its rigorous guidance through the experimental setups, observations, and analyses, the article is easy to read and follow, even for someone who is not a luminary on norovirus but certainly wants to broaden one’s horizon.

Future Direction

Even though this paper demonstrates the positive effect of PA depletion on viral infection, the mechanistic mode of action of PAs and the mechanistic utilization of PAs by the virus remain unknown. Further analyses could therefore focus in particular on PA in the context of viral protein translation and virus assembly. Furthermore, it is essential to investigate the effect of PAs in in vivo studies, especially if the focus of the work is to be on a therapeutic approach.

References

[1] Burke, R. M. & Hall, A. J. in Norovirus Vol. 1 (ed Melhem, N. M.) Ch. 1–29 (Springer Nature Switzerland AG, 2021)
[2] Atmar RL. Noroviruses: state of the art. Food Environ. Virol. 2010;2:117–126. doi: 10.1007/s12560-010-9038-1.
[3] Carlson, K. B., Dilley, A., O’Grady, T., Johnson, J. A., Lopman, B., & Viscidi, E. (2024). A narrative review of norovirus epidemiology, biology, and challenges to vaccine development. NPJ vaccines, 9(1), 94. https://doi.org/10.1038/s41541-024-00884-2
[4] Tan M. (2021). Norovirus Vaccines: Current Clinical Development and Challenges. Pathogens (Basel, Switzerland), 10(12), 1641. https://doi.org/10.3390/pathogens10121641
[5] Owusu IA, Passalacqua KD, Mirabelli C, Lu J, Young VL, Hosmillo M, Quaye O, Goodfellow I, Ward VK, Wobus CE. 2022. Akt Plays Differential Roles during the Life Cycles of Acute and Persistent Murine Norovirus Strains in Macrophages. J Virol 96:e0192321.
[6] https://www.cdc.gov/norovirus/php/reporting/norostat-data.html ata | Norovirus | CDC (Last visited: 24.09.2025)

Tags: infection, virology

doi: https://doi.org/10.1242/prelights.41519

Read preprint (1 votes)

Author's response

Maryna Chaika and Stefan Taube shared

How can you rule out that the observed inhibition is not due to nonspecific cellular stress response?

DFMO and DENSpm are generally considered safe and well-tolerated compounds. Both compounds have been tested in multiple clinical trials, with minimal safety concerns reported by participants (Meyskens et al. 1994, J Natl Cancer Inst; Horn et al. 1987, Eur J Cancer Clin Oncol). In academic research, these drugs are also well characterized in terms of their cytotoxic profiles and effective concentrations.

To investigate the effects of DFMO and DENSpm against murine norovirus, we first performed dose titrations to determine effective concentrations for subsequent experiments. As expected, the concentrations we identified were consistent with those reported in previous studies on the antiviral activity of polyamine-depleting drugs (Mounce et al. 2017, Microbiol Mol Biol Rev).

To assess potential adverse effects, we evaluated metabolic activity and membrane integrity in both immortalized cells and 3D human intestinal enteroids treated with DFMO or DENSpm, or subjected to polyamine depletion. We observed no significant cytotoxicity following treatment. Apart from published data, our additional experiments showed that DFMO-treated cells remained capable of exogenous proteins synthesis, confirming that DFMO does not induce substantial cellular stress or impair overall cell health.

Do you see polyamide depletion as a realistic therapeutic strategy or rather as a tool to identify new antiviral targets?

Norovirus disease is an acute, self-limiting illness. While the symptoms can be quite severe and unpleasant, the disease usually resolves within 2–3 days in healthy individuals. This leaves only a narrow window for pharmacological intervention. However, in immunocompromised patients, norovirus can lead to chronic infection, with symptoms persisting for months. For these individuals, therapeutic options are limited. Traditional treatments such as nitazoxanide, ribavirin, and immunoglobulins, have shown inconsistent efficacy. Especially, with the effectiveness of nitazoxanide and ribavirin being questioned in the research community (Lewis et al. 2023, Antimicrob. Agents Chemother; González‑Morcillo et al. 2022, Clin Res Hepatol Gastroenterol).

Although polyamine depletion requires a relatively long timeframe (3–4 days) to take effect, we believe it may be a viable therapeutic strategy for chronically infected patients. Such individuals could undergo treatment for sufficient time for DFMO to exert its antiviral effects and, if needed, they could even receive long-term therapy, as DFMO has been reported to be safe and well tolerated for periods of up to three months (Meyskens et al. 1994, J Natl Cancer Inst). Importantly, DFMO is already approved for clinical use in both USA and Europe for the treatment of trypanosomiasis, which opens a possibility of its off-label use.

All above-mentioned facts and confirmed effectiveness of DFMO in reduction of polyamine levels in gastrointestinal mucosa (Meyskens et al. 1998, J Natl Cancer Inst), supporting polyamine depletion as a realistic therapeutically strategy for chronic norovirus infections.

Do you think polyamide depletion could be combined with already established antiviral agents to observe possible additive effects?

Among the currently available antiviral options for chronic norovirus infection, such as immunoglobulins, nitazoxanide and ribavirin, only immunoglobulins have support in the literature as an effective treatment (van Kampen et al. 2022, J Infect Dis; Chung et al. 2024, Am J Gastroenterol; Buskandar et al. 2025, Am J Transplant). Combining immunoglobulins with polyamine depletion therapy may represent a promising strategy to quicken symptom resolution in patients. However, the potential additive effect of such a combination would need to be confirmed through controlled studies.

Have your say

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Sign up to customise the site to your preferences and to receive alerts

Register here

Also in the immunology category:

Citrobacter rodentium infection activates colonic lamina propria group 2 innate lymphoid cells

Rita Berkachy, Vishwas Mishra, Priyanka Biswas, et al.

Selected by 02 December 2025

André Luiz Amorim Costa, Marcus Oliveira

Immunology

Gut microbial composition modulates food-specific CD4+ T cells in food allergy

Alexa R Weingarden, Flannery S Dahlberg, Caroline N Broude, et al.

Selected by 28 November 2025

Mitchell Sarmie, Serena Restori

Immunology

A major histocompatibility complex (MHC) class II molecule that binds the same viral pathogen peptide with both nonamer and decamer core sequences for presentation to T cells

Anastasia Goryanin, Atlanta G. Cook, Shahriar Behboudi, et al.

Selected by 05 November 2025

Mitchell Sarmie

Immunology

Also in the microbiology category:

Citrobacter rodentium infection activates colonic lamina propria group 2 innate lymphoid cells

Rita Berkachy, Vishwas Mishra, Priyanka Biswas, et al.

Selected by 02 December 2025

André Luiz Amorim Costa, Marcus Oliveira

Immunology

Schistosoma haematobium DNA and Eggs in the Urine Sample of School-Age Children (SAC) in South-West Nigeria

Taiwo Mofadeke Jaiyeola, Folahanmi Tomiwa Akinsolu, Adesola Zaidat Musa, et al.

Selected by 24 November 2025

Hala Taha

Epidemiology

Stress granules formed during different RNA virus infections show remarkable plasticity and substantial virus-specific differences in their formation and composition

Reto M. Lang, Silvio Steiner, Jenna Kelly, et al.

Selected by 03 November 2025

Mohammed JALLOH

Cell Biology

Also in the molecular biology category:

Schistosoma haematobium DNA and Eggs in the Urine Sample of School-Age Children (SAC) in South-West Nigeria

Taiwo Mofadeke Jaiyeola, Folahanmi Tomiwa Akinsolu, Adesola Zaidat Musa, et al.

Selected by 24 November 2025

Hala Taha

Epidemiology

Lipid bilayer thinning near a ubiquitin ligase selects ER membrane proteins for degradation

Rudolf Pisa, Tom A. Rapoport

Selected by 21 November 2025

Ana Sanchez-Molina

Molecular Biology

HAK-actin, U-ExM-compatible probe to image the actin cytoskeleton

Olivier Mercey, Luc Reymond, Florent Lemaître, et al.

Selected by 17 November 2025

Kanishka Parashar

Cell Biology

preLists in the immunology category:

Community-driven preList – Immunology

In this community-driven preList, a group of preLighters, with expertise in different areas of immunology have worked together to create this preprint reading list.

 



List by Felipe Del Valle Batalla et al.

Journal of Cell Science meeting ‘Imaging Cell Dynamics’

This preList highlights the preprints discussed at the JCS meeting 'Imaging Cell Dynamics'. The meeting was held from 14 - 17 May 2023 in Lisbon, Portugal and was organised by Erika Holzbaur, Jennifer Lippincott-Schwartz, Rob Parton and Michael Way.

 



List by Helen Zenner

Fibroblasts

The advances in fibroblast biology preList explores the recent discoveries and preprints of the fibroblast world. Get ready to immerse yourself with this list created for fibroblasts aficionados and lovers, and beyond. Here, my goal is to include preprints of fibroblast biology, heterogeneity, fate, extracellular matrix, behavior, topography, single-cell atlases, spatial transcriptomics, and their matrix!

 



List by Osvaldo Contreras

Single Cell Biology 2020

A list of preprints mentioned at the Wellcome Genome Campus Single Cell Biology 2020 meeting.

 



List by Alex Eve

Autophagy

Preprints on autophagy and lysosomal degradation and its role in neurodegeneration and disease. Includes molecular mechanisms, upstream signalling and regulation as well as studies on pharmaceutical interventions to upregulate the process.

 



List by Sandra Malmgren Hill

Antimicrobials: Discovery, clinical use, and development of resistance

Preprints that describe the discovery of new antimicrobials and any improvements made regarding their clinical use. Includes preprints that detail the factors affecting antimicrobial selection and the development of antimicrobial resistance.

 



List by Zhang-He Goh

Zebrafish immunology

A compilation of cutting-edge research that uses the zebrafish as a model system to elucidate novel immunological mechanisms in health and disease.

 



List by Shikha Nayar

Also in the molecular biology category:

October in preprints – DevBio & Stem cell biology

Each month, preLighters with expertise across developmental and stem cell biology nominate a few recent developmental and stem cell biology (and related) preprints they’re excited about and explain in a single paragraph why. Short, snappy picks from working scientists — a quick way to spot fresh ideas, bold methods and papers worth reading in full. These preprints can all be found in the October preprint list published on the Node.

 



List by Deevitha Balasubramanian et al.

October in preprints – Cell biology edition

Different preLighters, with expertise across cell biology, have worked together to create this preprint reading list for researchers with an interest in cell biology. This month, most picks fall under (1) Cell organelles and organisation, followed by (2) Mechanosignaling and mechanotransduction, (3) Cell cycle and division and (4) Cell migration

 



List by Matthew Davies et al.

September in preprints – Cell biology edition

A group of preLighters, with expertise in different areas of cell biology, have worked together to create this preprint reading list. This month, categories include: (1) Cell organelles and organisation, (2) Cell signalling and mechanosensing, (3) Cell metabolism, (4) Cell cycle and division, (5) Cell migration

 



List by Sristilekha Nath et al.

June in preprints – the CellBio edition

A group of preLighters, with expertise in different areas of cell biology, have worked together to create this preprint reading lists for researchers with an interest in cell biology. This month, categories include: (1) Cell organelles and organisation (2) Cell signaling and mechanosensation (3) Genetics/gene expression (4) Biochemistry (5) Cytoskeleton

 



List by Barbora Knotkova et al.

May in preprints – the CellBio edition

A group of preLighters, with expertise in different areas of cell biology, have worked together to create this preprint reading lists for researchers with an interest in cell biology. This month, categories include: 1) Biochemistry/metabolism 2) Cancer cell Biology 3) Cell adhesion, migration and cytoskeleton 4) Cell organelles and organisation 5) Cell signalling and 6) Genetics

 



List by Barbora Knotkova et al.

Keystone Symposium – Metabolic and Nutritional Control of Development and Cell Fate

This preList contains preprints discussed during the Metabolic and Nutritional Control of Development and Cell Fate Keystone Symposia. This conference was organized by Lydia Finley and Ralph J. DeBerardinis and held in the Wylie Center and Tupper Manor at Endicott College, Beverly, MA, United States from May 7th to 9th 2025. This meeting marked the first in-person gathering of leading researchers exploring how metabolism influences development, including processes like cell fate, tissue patterning, and organ function, through nutrient availability and metabolic regulation. By integrating modern metabolic tools with genetic and epidemiological insights across model organisms, this event highlighted key mechanisms and identified open questions to advance the emerging field of developmental metabolism.

 



List by Virginia Savy, Martin Estermann

April in preprints – the CellBio edition

A group of preLighters, with expertise in different areas of cell biology, have worked together to create this preprint reading lists for researchers with an interest in cell biology. This month, categories include: 1) biochemistry/metabolism 2) cell cycle and division 3) cell organelles and organisation 4) cell signalling and mechanosensing 5) (epi)genetics

 



List by Vibha SINGH et al.

Biologists @ 100 conference preList

This preList aims to capture all preprints being discussed at the Biologists @100 conference in Liverpool, UK, either as part of the poster sessions or the (flash/short/full-length) talks.

 



List by Reinier Prosee, Jonathan Townson

February in preprints – the CellBio edition

A group of preLighters, with expertise in different areas of cell biology, have worked together to create this preprint reading lists for researchers with an interest in cell biology. This month, categories include: 1) biochemistry and cell metabolism 2) cell organelles and organisation 3) cell signalling, migration and mechanosensing

 



List by Barbora Knotkova et al.

Community-driven preList – Immunology

In this community-driven preList, a group of preLighters, with expertise in different areas of immunology have worked together to create this preprint reading list.

 



List by Felipe Del Valle Batalla et al.

January in preprints – the CellBio edition

A group of preLighters, with expertise in different areas of cell biology, have worked together to create this preprint reading lists for researchers with an interest in cell biology. This month, categories include: 1) biochemistry/metabolism 2) cell migration 3) cell organelles and organisation 4) cell signalling and mechanosensing 5) genetics/gene expression

 



List by Barbora Knotkova et al.

2024 Hypothalamus GRC

This 2024 Hypothalamus GRC (Gordon Research Conference) preList offers an overview of cutting-edge research focused on the hypothalamus, a critical brain region involved in regulating homeostasis, behavior, and neuroendocrine functions. The studies included cover a range of topics, including neural circuits, molecular mechanisms, and the role of the hypothalamus in health and disease. This collection highlights some of the latest advances in understanding hypothalamic function, with potential implications for treating disorders such as obesity, stress, and metabolic diseases.

 



List by Nathalie Krauth

BSCB-Biochemical Society 2024 Cell Migration meeting

This preList features preprints that were discussed and presented during the BSCB-Biochemical Society 2024 Cell Migration meeting in Birmingham, UK in April 2024. Kindly put together by Sara Morais da Silva, Reviews Editor at Journal of Cell Science.

 



List by Reinier Prosee

‘In preprints’ from Development 2022-2023

A list of the preprints featured in Development's 'In preprints' articles between 2022-2023

 



List by Alex Eve, Katherine Brown

CSHL 87th Symposium: Stem Cells

Preprints mentioned by speakers at the #CSHLsymp23

 



List by Alex Eve

9th International Symposium on the Biology of Vertebrate Sex Determination

This preList contains preprints discussed during the 9th International Symposium on the Biology of Vertebrate Sex Determination. This conference was held in Kona, Hawaii from April 17th to 21st 2023.

 



List by Martin Estermann

Alumni picks – preLights 5th Birthday

This preList contains preprints that were picked and highlighted by preLights Alumni - an initiative that was set up to mark preLights 5th birthday. More entries will follow throughout February and March 2023.

 



List by Sergio Menchero et al.

CellBio 2022 – An ASCB/EMBO Meeting

This preLists features preprints that were discussed and presented during the CellBio 2022 meeting in Washington, DC in December 2022.

 



List by Nadja Hümpfer et al.

EMBL Synthetic Morphogenesis: From Gene Circuits to Tissue Architecture (2021)

A list of preprints mentioned at the #EESmorphoG virtual meeting in 2021.

 



List by Alex Eve

FENS 2020

A collection of preprints presented during the virtual meeting of the Federation of European Neuroscience Societies (FENS) in 2020

 



List by Ana Dorrego-Rivas

ECFG15 – Fungal biology

Preprints presented at 15th European Conference on Fungal Genetics 17-20 February 2020 Rome

 



List by Hiral Shah

ASCB EMBO Annual Meeting 2019

A collection of preprints presented at the 2019 ASCB EMBO Meeting in Washington, DC (December 7-11)

 



List by Madhuja Samaddar et al.

Lung Disease and Regeneration

This preprint list compiles highlights from the field of lung biology.

 



List by Rob Hynds

MitoList

This list of preprints is focused on work expanding our knowledge on mitochondria in any organism, tissue or cell type, from the normal biology to the pathology.

 



List by Sandra Franco Iborra